Bioregenx (BRGX) Operating Expenses (2022 - 2026)

Bioregenx's Operating Expenses history runs 5 years deep, the most recent figure standing at $398052.0 for Q1 2026.

• In Q1 2026, Operating Expenses fell 33.51% year-over-year to $398052.0; the TTM figure through Mar 2026 stood at $2.5 million (down 88.18% YoY), while the FY2025 annual figure was $2.7 million, down 88.75% from the prior year.
• Operating Expenses was $398052.0 for Q1 2026 at Bioregenx, down from $1.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $18.6 million in Q4 2024 to a low of $13474.0 in Q3 2022.
• Historically, Operating Expenses has averaged $2.0 million across 5 years, with a median of $598646.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses surged 22460.15% in 2023, then plunged 93.27% in 2025.
• A 5-year view of Operating Expenses shows it stood at $14449.0 in 2022, then soared by 3980.42% to $589580.0 in 2023, then jumped by 3061.5% to $18.6 million in 2024, then slumped by 93.27% to $1.3 million in 2025, then slumped by 68.27% to $398052.0 in 2026.
• The last three Operating Expenses figures came in at $398052.0 (Q1 2026), $1.3 million (Q4 2025), and $434856.0 (Q3 2025), per Business Quant data.